Gosset Ownership
Private
Employees
~100
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Remilk General Information
Remilk has developed and commercialized a proprietary precision fermentation process that enables large-scale production of animal-free milk proteins. Their products are free from lactose, cholesterol, hormones, and antibiotics. The company has received regulatory approvals including self-GRAS status in the US and Health Canada’s “Letter of No Objection,” making it the first to receive such approval for non-animal dairy protein in Canada. Plans for large-scale manufacturing facilities have been announced but some have been postponed.
Contact Information
Drug Pipeline
r-βLG
CommercialKey Partnerships
EuropaBio membership (industry association), Collaborations with global food manufacturers (specific partners not disclosed)
Remilk Funding
No funding data available
To view Remilk's complete valuation and funding history, request access »